AUS
NZ
UK
CA
USA
IND
_07_03_2026_03_50_21_133108.jpg)
Integrated Diagnostics Holdings PLC (IDHC), the Cairo-based leader in diagnostic services, has experienced very limited shareholder acceptance during the initial two weeks of Hena Holdings Ltd's unrecommended mandatory cash offer. As of 23 July 2026, Bidco had received valid acceptances for only 900 shares, equating to roughly 0.00% of the current issued ordinary share capital. When combined with the 288,445,383 shares already owned by Bidco following its June 2026 acquisition from Elliott Investment Management, the bidder now holds approximately 49.61% of IDH's shares, falling short of the acceptance threshold needed to make the offer unconditional.
Key Points
- Integrated Diagnostics Holdings PLC (IDHC) faces an unrecommended mandatory cash offer from Hena Holdings Ltd at US$0.50 per share
- Bidco has secured acceptances for only 900 shares within the first 15 days of the offer, indicating negligible participation from independent shareholders
- Bidco's total holdings now amount to 288,446,283 shares (49.61%), including shares acquired from Elliott Investment Management and recent acceptances
- The offer remains open until 1:00 p.m. on 29 July 2026, with shareholders encouraged to respond before the deadline
Elliott Investment Triggers Mandatory Offer Under Takeover Code
On 23 June 2026, Hena Holdings Ltd, wholly owned by Dr Hend El Sherbini (IDH CEO) and her mother Dr Moamena Abdul Wahab Kamel, completed the purchase of 126,000,000 IDH shares from Actis IDH Limited, an entity controlled by Elliott Investment Management L.P. This acquisition triggered Rule 9 of the Takeover Code, mandating a mandatory cash offer to all remaining shareholders when a controlling interest is obtained or as required by regulations.
The mandatory offer was officially announced on 23 June 2026 at a fixed price of US$0.50 per share in cash. The offer document detailing terms, conditions, and acceptance procedures was distributed to IDH shareholders on 8 July 2026. This regulatory process ensures equitable treatment of all shareholders and offers a transparent exit opportunity at a predetermined price during the offer period.
Shareholder Acceptance Remains Significantly Below 50% at Midpoint
The acceptance update filed on 24 July 2026 highlights shareholder hesitancy. Between the offer opening on 9 July 2026 and close of business on 23 July 2026, Bidco received valid acceptances for only 900 shares, representing approximately 0.00% of IDH's issued ordinary share capital, indicating minimal engagement from independent shareholders.
Combined with the 288,445,383 shares held by Bidco post-Elliott acquisition, the total credited shareholding towards the acceptance condition stands at 288,446,283 shares, or about 49.61% of the issued ordinary share capital. This leaves Bidco short of the threshold typically required for the offer to become unconditional based solely on acceptances, placing the decision in shareholders' hands during the remaining offer period.
IDH's Diagnostic Services and Strategic Market Role in the Middle East
Integrated Diagnostics Holdings is a leading diagnostic services provider operating primarily in Cairo and across the Middle East. The company delivers diagnostic testing and laboratory services to patients, healthcare providers, and institutions, playing a vital role in regional healthcare infrastructure. IDH generates revenue through diagnostic services and healthcare analytics.
Listed on the London Stock Exchange, IDH attracts institutional investors including Elliott Investment Management. The Middle Eastern diagnostic sector is growth-driven by rising demand for healthcare diagnostics, increased disease screening, and expansion of private healthcare. IDH's established market position and operational footprint make it strategically important in the region's healthcare delivery landscape.
Deadline of 29 July 2026 Limits Shareholder Response Time
The offer remains open until 1:00 p.m. on 29 July 2026, setting a clear deadline for shareholders to accept or reject. If the offer becomes unconditional before this date, the acceptance period will extend by at least 14 days, ensuring shareholders have adequate time to participate. Shareholders yet to accept are urged to act promptly given the limited time remaining.
Shareholders holding certificated shares must complete and return the Form of Acceptance as per paragraph 11.1 of Part 1 of the Offer Document. Those with uncertificated shares in the CREST system should follow the procedure in paragraph 11.2 of Part 1. The Receiving Agent, MUFG Corporate Markets, offers support via helpline at 0371 664 0321 (UK) or +44 (0)371 664 0321 (international), available 9:00 a.m. to 5:30 p.m. Monday to Friday, excluding UK public holidays.
Bidco's Controlling Stake Originates from Elliott Acquisition
The 126,000,000 shares acquired from Elliott Investment Management in June 2026 gave Hena Holdings a substantial controlling interest in IDH. Elliott, a prominent activist fund, held these shares through Actis IDH Limited. The sale to Dr Hend El Sherbini and her mother marked a significant ownership change and triggered the mandatory offer.
Bidco’s total holding of 288,445,383 shares post-transaction represents a dominant share capital position, effectively granting control over IDH’s board and strategic direction. This ownership concentration diminishes the influence of independent shareholders and may impact shareholder behavior and expectations during the offer period.
US Shareholders Face Unique Tax and Regulatory Considerations
The announcement includes provisions for US holders of IDH shares, reflecting the company’s international shareholder base. The offer is a contractual takeover under the Takeover Code and English law, complying with Section 14(e) and Regulation 14E of the US Exchange Act. US shareholders should note that payment and settlement follow UK rules, which differ significantly from US tender offer procedures, especially regarding timing of payment.
US shareholders are warned that cash received for IDH shares will likely be taxable under US federal, state, local, and foreign tax laws. They are strongly advised to consult independent tax professionals promptly to understand the tax implications applicable to their circumstances.
Canaccord Genuity Serves as Exclusive Financial Adviser to Bidco
Canaccord Genuity Limited, authorised and regulated by the Financial Conduct Authority, acts as sole financial adviser to Bidco for the mandatory offer. The firm manages financial advisory, corporate actions, and shareholder communications throughout the offer period. Inquiries can be directed to Canaccord Genuity at +44 20 7523 8000, with Stuart Andrews and Harry Rees as contact points for bidder-side questions.
Canaccord Genuity coordinates with Receiving Agent MUFG Corporate Markets to administer acceptances, advises Bidco on offer strategy, and liaises with regulators to ensure compliance with the Takeover Code. This exclusive advisory arrangement streamlines decision-making and maintains consistent shareholder messaging.
Overseas Shareholders Must Adhere to Local Legal Restrictions
The announcement includes detailed notices for overseas shareholders, acknowledging the complexities of cross-border takeover offers. Shareholders outside the UK are cautioned that distribution of offer materials may be restricted by local laws. They should comply with all applicable legal and regulatory requirements before responding to the offer.
Bidco and its advisers disclaim responsibility for breaches of foreign legal restrictions and emphasize the offer’s preparation under English law, the Takeover Code, the Market Abuse Regulation, and Disclosure Guidance and Transparency Rules. Shareholders are encouraged to seek jurisdiction-specific legal advice before accepting.
Takeover Code Disclosure Obligations Remain in Effect During Offer
During the offer period, persons holding 1% or more of any IDH securities must comply with Takeover Code Rules 8.3(a) and 8.3(b) on opening position and dealing disclosures. Opening position disclosures detailing interests and short positions must be made by 3:30 p.m. London time on the tenth business day after the offer starts. Any dealings before this deadline require dealing disclosures.
Subsequent dealings must be disclosed by 3:30 p.m. on the business day following the transaction. Persons acting in concert are treated as a single entity for disclosure purposes. Details on IDH securities and offer dates are available at www.thetakeoverpanel.org.uk, with queries directed to the Market Surveillance Unit at +44 (0)20 7638 0129.
This article is for informational purposes only and does not constitute investment advice. All facts and figures are sourced from the RNS announcement dated 24 July 2026. Shareholders and prospective investors should review the full offer document and seek independent financial, legal, and tax advice before making decisions about the offer or their holdings. Investments carry risks and past performance does not guarantee future results. Acceptance or rejection decisions should be based on individual circumstances.
